Physician profile
Michael J Murphy
NPI 1972942308
$1,011.62
in general payments reported to CMS, 2019-2025
13 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $41.99 · 2021: $184 · 2022: $76.27 · 2023: $89.97 · 2024: $131 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $181.41 | 2019-2025 | Hym/Hyn, Hymovis, Hymhyn |
| Abbott Laboratories | $162.27 | 2021 | |
| Electronic Waveform Lab, INC. | $150.96 | 2019 | |
| Depuy Synthes Sales INC. | $108.82 | 2019-2025 | Orthovisc, Monovisc |
| Amgen INC. | $94.31 | 2020-2025 | Krystexxa, Prolia, Evenity |
| Smith+Nephew, INC. | $69.91 | 2019-2024 | Grafix Pl |
| Peerless Surgical INC. | $69.66 | 2024-2025 | |
| Shoulder Innovations, INC. | $47.38 | 2025 | Inset System |
| Bioventus LLC | $42.65 | 2023-2025 | Durolane, Durolane |
| Trice Medical, INC. | $26.67 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $20.10 | 2023 | Exparel, Iovera, Zilretta |
| Vericel Corporation | $19.05 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.